Patient information may be excluded from EU pharmaceutical package
This article was originally published in SRA
Executive Summary
The European Commission says that it is likely to delay a legislative proposal on the provision of information to patients, which is part of its larger “pharmaceutical package” that was unveiled late last year1,2. Faraz Kermani reports from the European Federation of Pharmaceutical Industries and Associations annual general meetings in Seville, Spain, on 13-15 May.